Results 201 to 210 of about 7,452,059 (286)

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić   +4 more
wiley   +1 more source

The integration of the British Pharmacological Society's prescription safety assessment into the WHO 6‐step model of rational pharmacotherapy in a Turkish medical school

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims At Koç University School of Medicine, a one‐week rational pharmacotherapy (RPHM) programme, modelled after WHO 6‐step, has been introduced in the fourth‐year curriculum to improve prescription skills. For efficient problem‐based learning (PBL) sessions on a prespecified topic, students need to brush up on basic pharmacology knowledge, so we ...
Sinem Ezgi Gülmez   +2 more
wiley   +1 more source

Perspectives of adult advanced pre-dialysis chronic kidney disease patients about kidney replacement therapy in three referral hospitals in Rwanda. [PDF]

open access: yesBMC Nephrol
Shumbusho G   +15 more
europepmc   +1 more source

Electronic medicine management systems in developing countries: A landscape review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Medicines are a major global health expense. However, suboptimal use increases costs and causes patient harm. One way to reduce costs and increase safe, efficient medicines use is with electronic medicines management systems (EMMS). They allow easy capture of routine health data which can facilitate research, service planning and reimbursement ...
Andrew Lambarth   +8 more
wiley   +1 more source

A real-world analysis of the impact of X-linked myotubular myopathy on caregivers in the United States. [PDF]

open access: yesOrphanet J Rare Dis
Duong T   +8 more
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Quality of Life Among Patients With Ductal Carcinoma In Situ.

open access: yesJAMA Netw Open
Dunsmore VJ   +17 more
europepmc   +1 more source

Financial toxicity of hemophilia care in Southeast Asian countries. [PDF]

open access: yesLancet Reg Health Southeast Asia
Antonio JM   +5 more
europepmc   +1 more source

Choice and diversity in governance in the English alternative provision sector: Implications for educational equity

open access: yesBritish Educational Research Journal, EarlyView.
Abstract Despite the continued global prevalence of discourses of educational inclusion, young people across local, national and international contexts continue to be educated outside of mainstream schools. In England, a diverse market of providers—known as alternative provision (AP)—cater for many of these young people.
Jodie Pennacchia   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy